The Use of Virtual Reality Glasses in Women With Premature Rupture of Membranes

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-50
SponsorSelcuk University

About this trial

The Effect of Virtual Reality Glass Use on Fetal Health Anxiety, Prenatal Distress, and Maternal-Fetal Attachment in Women with Premature Rupture of Membranes: A Randomized Controlled Trial

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Being 18 years of age or older

Being nulliparous

Having a diagnosis of preterm premature rupture of membranes (PPROM)

Being between 24 and 37 weeks of gestation

Disqualifiers

Having an additional diagnosis besides preterm premature rupture of membranes (PPROM) (e.g., preeclampsia, fetal distress, fetal anomalies, gestational diabetes, bleeding, etc.)

Having a chronic disease (e.g., hypertension, diabetes mellitus, thyroid disorders, etc.)

Having conceived through assisted reproductive technologies (ART)

Having any skin infection.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Standard prenatal care

    Other intervention

    The control group will receive standard prenatal care and treatment provided by the hospital. After the study is completed, control group participants will be shown nature-themed videos via Virtual Reality Glasses (VRG) if they wish.

  • Nature-themed video

    Other intervention

    Pregnant women with premise rupture of membranes (PRM) in the intervention group will be shown a nature-themed video prepared by the researchers with nature sounds via Virtual Reality Glasses (VRG) twice a day for at least five minutes each time for three days.

Treatment groups

176 Participants
are divided into 2 treatment groups
Group A: Standard prenatal carePlacebo comparator 2 interventions
Group B: Nature-themed videoExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Comparison of sociodemographic characteristics of pregnant women with premature rupture of membranes prior to intervention using questionnaires.

Sociodemographic information of pregnant women will be collected, compared, and reported through questionnaires.

Time frame
6 months
2

Comparison of mean scores on the Fetal Health Concern Scale among groups of pregnant women.

The Fetal Health Concern Scale will be administered to pregnant women. The Fetal Health Concern Scale ranges from 0 to 42 points (minimum-maximum), with higher scores indicating greater fetal health concern.

Time frame
6 months
3

Comparison of mean Prenatal Distress Scale scores among groups of pregnant women.

The Prenatal Distress Scale will be administered to all pregnant women. The Prenatal Distress Scale ranges from 0 to 34 points (minimum-maximum), with higher scores indicating greater prenatal distress.

Time frame
6 months
4

Comparison of mean Prenatal Attachment Inventory scores among groups of pregnant women.

The Prenatal Attachment Inventory will be administered to all pregnant women. The Prenatal Attachment Inventory score ranges from 21 to 84 points (minimum-maximum), with higher scores indicating greater prenatal distress.

Time frame
6 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.